AMGN
Amgen Inc.
- Selling, general and administrative, 2025
- $7.1B
- YoY, 2025
- −0.6%
- 5-year CAGR
- +4.2%
- 10-year CAGR
- +3.8%
Selling, general and administrative
Selling, general and administrative by fiscal year
| Period | SG&A | YoY |
|---|---|---|
| 2025 | $7.1B | −0.6% |
| 2024 | $7.1B | +14.8% |
| 2023 | $6.2B | +14.1% |
| 2022 | $5.4B | +0.9% |
| 2021 | $5.4B | −6.3% |
| 2020 | $5.7B | +11.3% |
| 2019 | $5.2B | −3.4% |
| 2018 | $5.3B | +9.5% |
| 2017 | $4.9B | −3.8% |
| 2016 | $5.1B | +4.5% |
| 2015 | $4.8B | +3.1% |
| 2014 | $4.7B | −9.4% |
| 2013 | $5.2B | +7.7% |
| 2012 | $4.8B | +7.0% |
| 2011 | $4.5B | +13.0% |
| 2010 | $4.0B | +4.3% |
| 2009 | $3.8B | +0.8% |
| 2008 | $3.8B | +12.7% |
| 2007 | $3.4B | — |